Page last updated: 2024-11-04

sulfadiazine and Vaginosis, Bacterial

sulfadiazine has been researched along with Vaginosis, Bacterial in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Vaginosis, Bacterial: Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TINSLEY, WH1

Other Studies

1 other study available for sulfadiazine and Vaginosis, Bacterial

ArticleYear
A short term treatment for trichomonas, monilial, and nonspecific vaginitis; preliminary report of results with gyneben.
    Texas state journal of medicine, 1955, Volume: 51, Issue:1

    Topics: Candida; Candidiasis; Disease; Female; Humans; Iodoquinol; Sulfadiazine; Trichomonas; Trichomonas In

1955